(en) Hien Nguyen, Connie Le et Hanh Nguyen, « Acute lyme infection presenting with amyopathic dermatomyositis and rapidly fatal interstitial pulmonary fibrosis: a case report », Journal of Medical Case Reports, vol. 4, no 1, , p. 187 (ISSN1752-1947, DOI10.1186/1752-1947-4-187, lire en ligne, consulté le )
(en) Paula David, Saptarshi Sinha, Khizer Iqbal, Gabriele De Marco, Sahar Taheri, Ella McLaren et al., « MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C) », The Lancet, vol. 104, no 105136, (DOI10.1016/j.ebiom.2024.105136, lire en ligne, consulté le ).
(en) Garima Singh, Sri Krishna jayadev Magani, Rinku Sharma, Basharat Bhat, Ashish Shrivastava, Madhusudhan Chinthakindi et Ashutosh Singh, « Structural, functional and molecular dynamics analysis of cathepsin B gene SNPs associated with tropical calcific pancreatitis, a rare disease of tropics : Table 1: The Single Nucleotide Polymorphisms in cathepsin B protein mined from literature », PeerJ, (PMID16492714, DOI10.7717/peerj.7425, lire en ligne, consulté le )
(en) H. W. Horowitz, K. Sanghera, N. Goldberg et D. Pechman, « Dermatomyositis Associated with Lyme Disease: Case Report and Review of Lyme Myositis », Clinical Infectious Diseases, vol. 18, no 2, , p. 166–171 (ISSN1058-4838 et 1537-6591, DOI10.1093/clinids/18.2.166, lire en ligne, consulté le )
(en) Jörg C. Hoffmann, Dirk O. Stichtenoth, Henning Zeidler et Markus Follmann, « Lyme disease in a 74-year-old forest owner with symptoms of dermatomyositis », Arthritis & Rheumatism, vol. 38, no 8, , p. 1157–1160 (DOI10.1002/art.1780380820, lire en ligne, consulté le )
(en) Hien Nguyen, Connie Le et Hanh Nguyen, « Acute lyme infection presenting with amyopathic dermatomyositis and rapidly fatal interstitial pulmonary fibrosis: a case report », Journal of Medical Case Reports, vol. 4, no 1, , p. 187 (ISSN1752-1947, DOI10.1186/1752-1947-4-187, lire en ligne, consulté le )
Victoria P. Werth, Emily Hejazi, Sandra M. Pena et Jessica Haber, « Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial », The Journal of Investigative Dermatology, vol. 142, no 10, , p. 2651–2659.e1 (ISSN1523-1747, PMID35490744, DOI10.1016/j.jid.2022.03.029, lire en ligne, consulté le )
(en) H. W. Horowitz, K. Sanghera, N. Goldberg et D. Pechman, « Dermatomyositis Associated with Lyme Disease: Case Report and Review of Lyme Myositis », Clinical Infectious Diseases, vol. 18, no 2, , p. 166–171 (ISSN1058-4838 et 1537-6591, DOI10.1093/clinids/18.2.166, lire en ligne, consulté le )
(en) Hien Nguyen, Connie Le et Hanh Nguyen, « Acute lyme infection presenting with amyopathic dermatomyositis and rapidly fatal interstitial pulmonary fibrosis: a case report », Journal of Medical Case Reports, vol. 4, no 1, , p. 187 (ISSN1752-1947, DOI10.1186/1752-1947-4-187, lire en ligne, consulté le )
Victoria P. Werth, Emily Hejazi, Sandra M. Pena et Jessica Haber, « Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial », The Journal of Investigative Dermatology, vol. 142, no 10, , p. 2651–2659.e1 (ISSN1523-1747, PMID35490744, DOI10.1016/j.jid.2022.03.029, lire en ligne, consulté le )
(en) Garima Singh, Sri Krishna jayadev Magani, Rinku Sharma, Basharat Bhat, Ashish Shrivastava, Madhusudhan Chinthakindi et Ashutosh Singh, « Structural, functional and molecular dynamics analysis of cathepsin B gene SNPs associated with tropical calcific pancreatitis, a rare disease of tropics : Table 1: The Single Nucleotide Polymorphisms in cathepsin B protein mined from literature », PeerJ, (PMID16492714, DOI10.7717/peerj.7425, lire en ligne, consulté le )
Victoria P. Werth, Emily Hejazi, Sandra M. Pena et Jessica Haber, « Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial », The Journal of Investigative Dermatology, vol. 142, no 10, , p. 2651–2659.e1 (ISSN1523-1747, PMID35490744, DOI10.1016/j.jid.2022.03.029, lire en ligne, consulté le )
pubmed.ncbi.nlm.nih.gov
Victoria P. Werth, Emily Hejazi, Sandra M. Pena et Jessica Haber, « Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial », The Journal of Investigative Dermatology, vol. 142, no 10, , p. 2651–2659.e1 (ISSN1523-1747, PMID35490744, DOI10.1016/j.jid.2022.03.029, lire en ligne, consulté le )
(en) H. W. Horowitz, K. Sanghera, N. Goldberg et D. Pechman, « Dermatomyositis Associated with Lyme Disease: Case Report and Review of Lyme Myositis », Clinical Infectious Diseases, vol. 18, no 2, , p. 166–171 (ISSN1058-4838 et 1537-6591, DOI10.1093/clinids/18.2.166, lire en ligne, consulté le )
(en) Paula David, Saptarshi Sinha, Khizer Iqbal, Gabriele De Marco, Sahar Taheri, Ella McLaren et al., « MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C) », The Lancet, vol. 104, no 105136, (DOI10.1016/j.ebiom.2024.105136, lire en ligne, consulté le ).
Oddis CV, Reed AM, Aggarwal R et al. |http://onlinelibrary.wiley.com/doi/10.1002/art.37754/abstractRituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial], Arthritis Rheum, 2013;65:314-324
doi.wiley.com
(en) Jörg C. Hoffmann, Dirk O. Stichtenoth, Henning Zeidler et Markus Follmann, « Lyme disease in a 74-year-old forest owner with symptoms of dermatomyositis », Arthritis & Rheumatism, vol. 38, no 8, , p. 1157–1160 (DOI10.1002/art.1780380820, lire en ligne, consulté le )
